US 12,343,274 B2
Implantable devices and techniques for the treatment of obesity
Sung Il Park, College Station, TX (US); Woo Seok Kim, College Station, TX (US); and Carlos Arturo Campos, Seattle, WA (US)
Assigned to The Texas A & M University System, College Station, TX (US); and University of Washington, Seattle, WA (US)
Filed by The Texas A&M University System, College Station, TX (US); and University of Washington, Seattle, WA (US)
Filed on Feb. 25, 2022, as Appl. No. 17/681,595.
Claims priority of provisional application 63/153,937, filed on Feb. 25, 2021.
Prior Publication US 2022/0265452 A1, Aug. 25, 2022
Int. Cl. A61F 5/00 (2006.01)
CPC A61F 5/0013 (2013.01) 8 Claims
OG exemplary drawing
 
1. An organ-specific wireless optogenetic device, the device comprising:
an electronic circuit, wherein the electronic circuit is configured to harvest and convert radio frequency (RF) energy into optical energy; and
a tether coupled to the electronic circuit and comprising a μLED, wherein when the device is implanted in a subject the μLED illuminates targeted regions in the organ, wherein a portion of the tether that comprises the μLED has a pre-curved, sandwiched configuration comprising copper/polyimide (Cu/PI) bilayer films, and wherein the μLED is sandwiched between two bilayer films.